Browsing the "Domain Associates" Tag →

22 2014 September
By FinSMEs
0 Comments

Colorescience Completes $15M Series B Financing

Colorescience, a Carlsbad, CA-based premier luxury mineral makeup company, completed a $15m Series B financing. The round was led by Longwood Fund...

Read More →
04 2014 September
By FinSMEs
0 Comments

Fractyl Laboratories Secures $40M in Series C Funding

Fractyl Laboratories, a Waltham, Mass.-based developer of a device-based endoscopic procedure to treat Type 2 diabetes, secured $40m in Series...

Read More →
30 2014 July
By FinSMEs
0 Comments

Epic Sciences Completes $30M Series C Financing

Epic Sciences, Inc., a San Diego, CA-based biotech company that designs and develops novel diagnostics to personalize and advance the...

Read More →
30 2014 April
By FinSMEs
0 Comments

Otonomy Secures $49M in Series D Financing

Otonomy, a San Diego, CA-based biopharmaceutical company developing therapeutics for diseases for the ear, secured $49m in Series D financing....

Read More →
08 2014 April
By FinSMEs
0 Comments

Sequent Medical Closes $20M Series D VC Financing

Sequent Medical, a Aliso Viejo, California-based medical-device company, closed a $20.0m Series D venture capital financing. The round was led...

Read More →
12 2014 February
By FinSMEs
0 Comments

Lithera Raises $8M in Series C Funding

Lithera, a San Diego, Calif.-based a clinical stage pharmaceutical company, raised $8m in the final close of its Series C...

Read More →
12 2014 February
By FinSMEs
0 Comments

Miramar Labs Raises $10M in Series D Funding

Miramar Labs®, Inc., a Sunnyvale, CA-based medical device manufacturer focused on the treatment of excessive underarm sweat, raised $10m in...

Read More →
10 2014 January
By FinSMEs
0 Comments

Atara Biotherapeutics Holds $13.5M Second Close of Series B Financing

Atara Biotherapeutics, Inc., a Thousand Oaks, CA-based drug development company with a focus on innovative therapies for patients with debilitating diseases,...

Read More →
17 2013 December
By FinSMEs
0 Comments

Atara Biotherapeutics Secures $38.5M in Series B Financing

Atara Biotherapeutics, Inc., a Thousand Oaks, CA-based drug development company with a focus on innovative therapies for patients with debilitating...

Read More →
02 2013 December
By FinSMEs
1 Comments

Xagenic Closes $20M Series B Financing

Xagenic Inc., a Toronto, Canada-based molecular diagnostics company, closed a $20m Series B financing. The round was led by new...

Read More →
14 2013 November
By FinSMEs
0 Comments

RightCare Solutions Secures $5M in Series B Funding

RightCare Solutions, Inc., a Philadelphia, PA-based medical technology company, secured $5.0m in Series B funding. The round was led by...

Read More →
03 2013 October
By FinSMEs
0 Comments

NovaDigm Therapeutics Closes $14M Series B Financing

NovaDigm Therapeutics, a Grand Forks, North Dakota-based developer of vaccines for fungal and bacterial infections, closed a $14m Series B...

Read More →
04 2013 September
By FinSMEs
0 Comments

Otonomy Completes $45.9M Series C Financing

Otonomy, Inc., a San Diego, CA-based clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner...

Read More →
27 2013 August
By FinSMEs
0 Comments

Syndax Pharmaceuticals Secures $26.6M Series B Financing

Syndax Pharmaceuticals Inc., a Waltham, MA-based developer of epigenetic therapies for treatment-resistant cancers, secured a $26.6m Series B financing. Backers included...

Read More →